Hosted on MSN43m
AbbVie and Simcere Zaiming link to develop trispecific antibodyThe humanised trispecific antibody is undergoing Phase I trials in the US and China in subjects with relapsed or refractory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback